Skip to main content
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Main navigation - Mobile
3. Allergan—$750 million
Allergan pays $750M to settle Namenda 'hard switch' suit
Monday, October 28, 2019
The suit alleged Allergan tried to pull Namenda off the market right before patent expiration to force patients onto its long-acting version.
Pressed to get asset sales in gear, Allergan delivers Q1 beat
Monday, April 30, 2018
Allergan may be facing investor pressure to sell some businesses—and boost its share price—but the company managed to beat the Street's Q1 estimates.
15. Namenda XR
Rounding out this year's list of top patent expirations is Allergan's Namenda XR, a drug that made headlines back in 2015 when its predecessor formula went generic. This long-acting version already faces copycat rivals.
With generics looming, Pfizer wins FDA nod for longer-acting Lyrica
Thursday, October 12, 2017
Bracing for generic competition to big-selling Lyrica, Pfizer has won FDA approval for a longer-lasting version that could help it defend sales.